Table 3.
Case number |
Diagnosis | Breed | Age (years) | Sex | Lesion distribution |
p16 | FcaPV type |
2−ΔΔCq* |
---|---|---|---|---|---|---|---|---|
1 | VP | DSH | 10 | M | Flank | + | 2 | 119 |
2 | VP | Persian | 15 | F | Groin | + | 2 | 53 |
3 | VP | DSH | 9 | M | Nose | + | 1 | 72 |
4 | VP | Maine Coon | 10 | F | Nose | + | 2 | 271 |
5 | BISC | DSH | 10 | F | Flank | + | − | |
6 | BISC | Maine Coon | 6 | M | Shoulder | + | 4 | 5836 |
7 | BISC | DSH | 13 | M | Nose | + | − | |
8 | BISC | DSH | 13 | F | Nose | + | 1 | 49 |
9 | BISC | DSH | 9 | F | Temporal | + | − | |
10 | BISC | DSH | 20 | F | Dorsal | + | ND | |
11 | BISC | DSH | 15 | M | Temporal | + | 2–4 | 224–331 |
12 | BISC | DSH | 15 | M | Nose | + | − | |
13 | BISC | DSH | 16 | F | Shoulder | + | − | |
14 | BISC | DSH | 12 | M | Ear | + | − | |
15 | BISC | DSH | 12 | M | Dorsum | + | 2 | 172 |
16 | BISC | DSH | 8 | F | Temporal | + | 1–2 | 58–167 |
17 | BISC | DSH | 10 | F | Temporal | + | − | |
18 | BISC | Persian | 15 | M | Eyelid | + | 2 | 211 |
19 | BISC | DSH | 10 | F | Ear | + | − | |
20 | BISC | DSH | 7 | F | Flank | + | − | |
21 | BISC | DSH | 10 | M | Nose | + | 2 | 159 |
22 | BISC | DSH | 15 | M | Shoulder | + | − | |
23 | BISC | DSH | 12 | M | Nose | + | 1–2 | 71–326 |
24 | BISC | DSH | 10 | M | Flank | + | − | |
25 | SCC | DSH | 9 | F | Ear | +/− | − | |
26 | SCC | DSH | 8 | M | Nose | +/− | − | |
27 | SCC | DSH | 15 | F | Ear | +/− | − | |
28 | SCC | DSH | 10 | M | Eyelid | +/− | − | |
29 | AK | DSH | 11 | F | Ear | +/− | − |
Indicates the fold change of FcaPV viral genomes normalised to albumin (ALB) compared with the negative control group (SCC and AK)
DSH = domestic shorthair; M = male; F = female; ND = not determined